Breast Cancer News
In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.
CHICAGO (Reuters) - Regulators are moving the goal posts in testing new drugs for breast cancer in the hopes of giving more women with aggressive, early-stage cancers the chance to try breakthrough drugs while they have the best shot at a cure.
CHICAGO (Reuters) - A study of Roche's experimental "armed antibody" found it extended the length of time breast cancer patients lived without their disease getting worse, marking the second successful pivotal trial in this new class of cancer drugs.
(Reuters) - A pair of newer drugs proved no better, and by some measures inferior, to the older and cheaper chemotherapy agent paclitaxel in patients with locally advanced or metastatic breast cancer, according to results of a late stage study.
Use of an ovarian suppression medicine during chemotherapy to protect ovaries of premenopausal women shows no difference for menstruation after treatment.
NEW YORK (Reuters Health) - Cancer treatment can sometimes lead to infertility, but young women are less likely than young men to be informed of that risk, a new study suggests.
(Reuters) - Interim results from a mid-stage trial of Celldex Therapeutics Inc's experimental drug showed trends toward reducing tumors in patients with advanced breast cancer, with rates improving for those patients with high levels of a key protein.
Children born to mothers who had chemotherapy during pregnancy show long-term normal development.
LONDON (Reuters) - Scientists have mapped the complete genetic codes of 21 breast cancers and created a catalogue of the mutations that accumulate in breast cells, raising hopes that the disease may be able to be spotted earlier and treated more effectively in future.
Younger women who want to become pregnant after treatment but are unable to conceive experience long-term emotional distress related to that infertility.
NEW YORK (Reuters Health) - New research suggests that starting breast cancer screening at age 40 might be worthwhile for some women who have a higher-than-average risk of the disease, for example because their mother had cancer.